Philly healthcare and life science investment firm 1315 Capital raises $300M+ for second fund
The investment firm plans to invest $10 million to $30 million in specialty pharma, and medtech companies.
The investment firm plans to invest $10 million to $30 million in specialty pharma, and medtech companies.
It plans to invest in 10 to 14 commercial-stage companies at $10 million to $20 million per business. Last year it co-founded surgical oncology startup Onkos Surgical.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.